Insights
Search Results
News Articles
6.04.26
Wilson Sonsini Practices, Attorneys Recognized in 2026 Chambers USA Guide
The 2026 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 44 geography-specific practice categories and named 87 Wilson Sonsini attorneys among the best in their fields. This year, the firm received four new practice area rankings, including in the nationwide National Security and Capital Markets: Convertible Debt categories, and three improved practice area rankings.
Client Highlights
5.29.26
Wilson Sonsini Advises Inherent on $50 Million Seed Round as Company Emerges from Stealth
On May 28, 2026, Inherent Laboratories (Inherent), a London-based AI lab, emerged from stealth and announced a $50 million Seed round led by Index Ventures and Radical Ventures, with participation from investors including NVentures (NVIDIA's venture capital arm), Ex/Ante, Metaplanet, Macroscopic Ventures, and Mythos Ventures. Wilson Sonsini Goodrich & Rosati advised Inherent on the transaction.
Client Highlights
3.31.26
Wilson Sonsini Advises Crosspoint Capital Partners on TENEX.AI’s $250 Million Series B
On March 31, 2026, TENEX.AI, the AI SOC company transforming security operations, announced a $250 million Series B round of financing led by Crosspoint Capital Partners. Wilson Sonsini Goodrich & Rosati advised Crosspoint on the transaction.
The proceeds from the Series B will accelerate TENEX.AI’s global expansion and significantly scale the human expertise behind its AI-native managed detection and response (MDR) service, expanding the team of defenders and engineers delivering cybersecurity outcomes. The TENEX.AI platform enables AI-driven triage, investigation, hunting, and response to threats in under a minute—with 100 percent alert coverage and human analysts governing every decision and accountable for every outcome.
The Wilson Sonsini team that advised Crosspoint on the financing included:
Corporate
Becki DeGraw
Travis Scheft
Michael Murrietta
Enid Qin
The proceeds from the Series B will accelerate TENEX.AI’s global expansion and significantly scale the human expertise behind its AI-native managed detection and response (MDR) service, expanding the team of defenders and engineers delivering cybersecurity outcomes. The TENEX.AI platform enables AI-driven triage, investigation, hunting, and response to threats in under a minute—with 100 percent alert coverage and human analysts governing every decision and accountable for every outcome.
The Wilson Sonsini team that advised Crosspoint on the financing included:
Corporate
Becki DeGraw
Travis Scheft
Michael Murrietta
Enid Qin
Client Highlights
2.10.26
Firm Advises IVP as Lead Investor in Solace Health’s $130 Million Series C
On February 10, 2026, Solace Health announced a $130 million Series C funding round led by IVP, accelerating the company’s mission to make advocacy a standard part of care for every patient in the United States. The Series C values Solace at over $1 billion and reflects growing consensus that healthcare advocacy is no longer optional as costs rise and systems fracture. Wilson Sonsini Goodrich & Rosati advised IVP on the transaction.
The round also included participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures. With this funding, Solace will significantly expand its national network of more than 2,000 experienced advocates serving Medicare and Medicare Advantage members, while accelerating investment in its platform and clinical research. The company will also deepen partnerships with payers and providers to embed advocacy earlier in the care journey where outcomes are most at risk.
The Wilson Sonsini team that advised IVP on the transaction included Becki DeGraw, Madeleine Vella, Andrea Linna, Nawa Lodin, Chris Paniewski, Isabel Annino, and Daniel Chen.
For more information, please see Solace Health’s news release. Additional coverage is available on Fierce Healthcare and MedCity News.
The round also included participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures. With this funding, Solace will significantly expand its national network of more than 2,000 experienced advocates serving Medicare and Medicare Advantage members, while accelerating investment in its platform and clinical research. The company will also deepen partnerships with payers and providers to embed advocacy earlier in the care journey where outcomes are most at risk.
The Wilson Sonsini team that advised IVP on the transaction included Becki DeGraw, Madeleine Vella, Andrea Linna, Nawa Lodin, Chris Paniewski, Isabel Annino, and Daniel Chen.
For more information, please see Solace Health’s news release. Additional coverage is available on Fierce Healthcare and MedCity News.
Client Highlights
12.11.25
Wilson Sonsini Advises IVP and Menlo Ventures on Harness’ $240 Million Series E
On December 11, 2025, Harness, an AI software delivery platform company, announced a $240 million Series E financing round, comprised of a $200 million investment led by Goldman Sachs Alternatives and a planned $40 million tender offer with participation from IVP, Menlo Ventures, and Unusual Ventures. Wilson Sonsini Goodrich & Rosati advised IVP and Menlo Ventures on the transaction.
Client Highlights
8.19.25
Wilson Sonsini Advises Aalo Atomics on $100 Million Series B
On August 19, 2025, Aalo Atomics, a nuclear engineering company created to make reactor deployment highly predictable and economical, announced a $100 million Series B. Led by Valor Equity Partners, the financing round also saw participation from 50Y, Alumni Ventures, Crescent Enterprises, Crosscut, Fine Structure Ventures, Gaingels, Harpoon Ventures, Hitachi Ventures, Kindred Ventures, MCJ, NRG Energy, Nucleation Capital, Perpetual VC, Tishman Speyer, and Vamos Ventures. Wilson Sonsini Goodrich & Rosati advised Aalo Atomics on the transaction.
News Articles
6.05.25
2025 Chambers USA Guide Recognizes Wilson Sonsini Practices, Attorneys
The 2025 Chambers USA guide has recognized Wilson Sonsini Goodrich & Rosati as a leading law firm in 39 geography-specific practice categories and named 86 Wilson Sonsini attorneys among the best in their fields. This year, the firm received three new practice area rankings, including in the Artificial Intelligence category, and four improved practice area rankings.
Client Highlights
5.05.25
Wilson Sonsini Advises J.P. Morgan Growth Equity Partners on Rogo’s $50 Million Series B
On April 30, 2025, Rogo, a generative AI start-up focused on financial services, announced the completion of a $50 million Series B financing round led by Thrive Capital, with participation from new investors J.P. Morgan Growth Equity Partners, Tiger Global, and Positive Sum Ventures. Wilson Sonsini Goodrich & Rosati advised J.P. Morgan Growth Equity Partners on the transaction.
Client Highlights
4.25.25
Wilson Sonsini Advises J.P. Morgan Growth Equity Partners on Nourish's $70 Million Series B
On April 23, 2025, Nourish, a leading provider of nutrition counseling, announced a $70 million Series B funding round led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Thrive Capital, Index Ventures, Y Combinator, Maverick Ventures, BoxGroup, Atomico, G Squared, and Pinegrove. Wilson Sonsini advised J.P. Morgan Private Capital’s Growth Equity Partners on the transaction.
Client Highlights
1.22.25
Wilson Sonsini Advises Divvy Homes on Sale of Portfolio and Platform to Brookfield
On January 22, 2025, Divvy Homes, a market leader in the proptech industry, announced that they have entered into a definitive agreement whereby a Brookfield private real estate fund will acquire Divvy Homes’ property portfolio and platform for a total consideration of approximately $1 billion. Maymont Homes, Brookfield’s single-family home rental business, will manage the portfolio on an ongoing basis. Wilson Sonsini Goodrich & Rosati advised Divvy Homes on the transaction.